{"id":"kd7040-topical-gel","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Skin irritation"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"KD7040 Topical Gel is a topical formulation of a small molecule inhibitor that targets a specific pathway. This allows for localized delivery and potentially reduced systemic side effects.","oneSentence":"KD7040 Topical Gel is a topical gel formulation of a small molecule inhibitor.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:58:07.298Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Actinic keratosis"}]},"trialDetails":[{"nctId":"NCT00576108","phase":"PHASE2","title":"A 2 Week Study of Topical KD7040 in the Treatment of Postherpetic Neuralgia (PHN)","status":"COMPLETED","sponsor":"Kalypsys, Inc.","startDate":"2007-11","conditions":"Postherpetic Neuralgia, Shingles, Herpes Zoster","enrollment":48}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":756,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"KD7040 Topical Gel","genericName":"KD7040 Topical Gel","companyName":"Kalypsys, Inc.","companyId":"kalypsys-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"KD7040 Topical Gel is a topical gel formulation of a small molecule inhibitor. Used for Actinic keratosis.","enrichmentLevel":3,"visitCount":2,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}